Federal Register Notice: FDA’s Science Board to the Food and Drug Administration will meet 5/ 20, from 9 a.m. to 4 p.m. at FDA, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503, Silver Spring, MD. For those unable to attend in person, the meeting will also be Web cast at https:// collaboration.fda.gov/scienceboard. The Science Board will discuss the report from the subcommittee’s review of the Pharmacovigilance Program at CDER. The board will receive updates on FDA’s nanotechnology research program plans and its activities in support of comparative effectiveness research. The board will also initiate the charge to the subcommittee for a science review of CDRH. Contact Martha Monser, (301) 796-4627. To view this notice, click here.